Two Sigma Investments’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-88,670
| Closed | -$402K | – | 4050 |
|
|
2025
Q3 | $402K | Buy |
88,670
+69,913
| +373% | +$206K | ﹤0.01% | 3089 |
|
|
2025
Q2 | $40.3K | Buy |
+18,757
| New | +$52.5K | ﹤0.01% | 3085 |
|
|
2024
Q4 | – | Sell |
-27,499
| Closed | -$193K | – | 3169 |
|
|
2024
Q3 | $193K | Sell |
27,499
-49,846
| -64% | -$362K | ﹤0.01% | 2804 |
|
|
2024
Q2 | $531K | Buy |
77,345
+65,503
| +553% | +$609K | ﹤0.01% | 2344 |
|
|
2024
Q1 | $167K | Sell |
11,842
-32,798
| -73% | -$499K | ﹤0.01% | 2752 |
|
|
2023
Q4 | $336K | Sell |
44,640
-7,164
| -14% | -$65.4K | ﹤0.01% | 2648 |
|
|
2023
Q3 | $777K | Buy |
51,804
+3,270
| +7% | +$58.7K | ﹤0.01% | 2068 |
|
|
2023
Q2 | $772K | Sell |
48,534
-13,578
| -22% | -$143K | ﹤0.01% | 2098 |
|
|
2023
Q1 | $446K | Sell |
62,112
-8,653
| -12% | -$61.2K | ﹤0.01% | 2251 |
|
|
2022
Q4 | $410K | Sell |
70,765
-34,041
| -32% | -$258K | ﹤0.01% | 2109 |
|
|
2022
Q3 | $996K | Sell |
104,806
-11,650
| -10% | -$153K | ﹤0.01% | 1474 |
|
|
2022
Q2 | $1.4M | Sell |
116,456
-40,404
| -26% | -$423K | ﹤0.01% | 1383 |
|
|
2022
Q1 | $2.06M | Sell |
156,860
-19,768
| -11% | -$289K | 0.01% | 1342 |
|
|
2021
Q4 | $3.11M | Sell |
176,628
-10,442
| -6% | -$209K | 0.01% | 1545 |
|
|
2021
Q3 | $4.06M | Buy |
187,070
+34,997
| +23% | +$893K | 0.01% | 1386 |
|
|
2021
Q2 | $5.32M | Buy |
152,073
+83,880
| +123% | +$4.52M | 0.01% | 1159 |
|
|
2021
Q1 | $6.72M | Buy |
68,193
+430
| +0.6% | +$51.6K | 0.02% | 895 |
|
|
2020
Q4 | $7.35M | Sell |
67,763
-38,516
| -36% | -$4.77M | 0.02% | 732 |
|
|
2020
Q3 | $10.9M | Buy |
106,279
+104,754
| +6,869% | +$15.7M | 0.04% | 477 |
|
|
2020
Q2 | $318K | Buy |
+1,525
| New | +$270K | ﹤0.01% | 2335 |
|
|
2019
Q4 | – | Sell |
-11,363
| Closed | -$619K | – | 3603 |
|
|
2019
Q3 | $619K | Buy |
+11,363
| New | +$1.28M | ﹤0.01% | 2377 |
|
|
2019
Q2 | – | Sell |
-7,473
| Closed | -$392K | – | 3276 |
|
|
2019
Q1 | $392K | Sell |
7,473
-19,806
| -73% | -$801K | ﹤0.01% | 2427 |
|
|
2018
Q4 | $859K | Buy |
27,279
+8,743
| +47% | +$356K | ﹤0.01% | 1748 |
|
|
2018
Q3 | $1.12M | Sell |
18,536
-18,560
| -50% | -$1.04M | ﹤0.01% | 1897 |
|
|
2018
Q2 | $1.97M | Buy |
37,096
+35,374
| +2,054% | +$2.13M | 0.01% | 1625 |
|
|
2018
Q1 | $100K | Sell |
1,722
-32,074
| -95% | -$2M | ﹤0.01% | 3036 |
|
|
2017
Q4 | $1.18M | Buy |
33,796
+26,295
| +351% | +$865K | ﹤0.01% | 1848 |
|
|
2017
Q3 | $274K | Buy |
7,501
+1,268
| +20% | +$35.2K | ﹤0.01% | 2467 |
|
|
2017
Q2 | $156K | Buy |
+6,233
| New | +$170K | ﹤0.01% | 2831 |
|
Two Sigma Investments's ADVM Position: Q4 2025 in Review
Two Sigma Investments sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 88,670 shares — an estimated $402K sold.
Two Sigma Investments first reported a position in ADVM in Q2 2017 and held it in 29 quarters. The position peaked at $10.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.
- Two Sigma Investments reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
- Two Sigma Investments sold 88,670 Adverum Biotechnologies shares in Q4 2025, an estimated $402K.
- Two Sigma Investments first reported a position in Adverum Biotechnologies in Q2 2017 and held it in 29 quarters.
- Two Sigma Investments's Adverum Biotechnologies position peaked at $10.9M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.
Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.